Ke Ying Liu
Directeur/Bestuurslid bij Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Actieve functies van Ke Ying Liu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Directeur/Bestuurslid | - | - |
Loopbaan van Ke Ying Liu
Eerdere bekende functies van Ke Ying Liu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| JIANGSU PROVINCIAL AGRICULTURAL RECLAMATION AND DEVELOPMENT CO.,LTD. | Voorzitter | - | 22-09-2023 |
Statistieken
Internationaal
| China | 3 |
Operationeel
| Chairman | 1 |
| Director/Board Member | 1 |
Sectoraal
| Process Industries | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| JIANGSU PROVINCIAL AGRICULTURAL RECLAMATION AND DEVELOPMENT CO.,LTD. | Process Industries |
| Bedrijven in privébezit | 1 |
|---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
- Beurs
- Insiders
- Ke Ying Liu
- Ervaring
